TRAZIMERA Trademark

Trademark Overview

On Wednesday, November 8, 2017, a trademark application was filed for TRAZIMERA with the United States Patent and Trademark Office. The USPTO has given the TRAZIMERA trademark a serial number of 87676593. The federal status of this trademark filing is REGISTERED as of Tuesday, January 19, 2021. This trademark is owned by Pfizer Inc.. The TRAZIMERA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
trazimera

General Information

Serial Number87676593
Word MarkTRAZIMERA
Filing DateWednesday, November 8, 2017
Status700 - REGISTERED
Status DateTuesday, January 19, 2021
Registration Number6251691
Registration DateTuesday, January 19, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 17, 2017
Primary Code005
First Use Anywhere DateTuesday, March 31, 2020
First Use In Commerce DateTuesday, March 31, 2020

Trademark Owner History

Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 100012192
Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, March 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 19, 2021REGISTERED-PRINCIPAL REGISTER
Thursday, December 17, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, December 16, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 23, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, November 13, 2020USE AMENDMENT FILED
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 13, 2020TEAS STATEMENT OF USE RECEIVED
Saturday, May 30, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2020SOU EXTENSION 3 GRANTED
Thursday, May 28, 2020SOU EXTENSION 3 FILED
Thursday, May 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 15, 2019SOU EXTENSION 2 GRANTED
Friday, November 15, 2019SOU EXTENSION 2 FILED
Friday, November 15, 2019SOU TEAS EXTENSION RECEIVED
Friday, May 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 22, 2019SOU EXTENSION 1 GRANTED
Wednesday, May 22, 2019SOU EXTENSION 1 FILED
Wednesday, May 22, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, December 11, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 6, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 22, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 22, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 21, 2018ASSIGNED TO LIE
Wednesday, August 1, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 8, 2018NON-FINAL ACTION E-MAILED
Thursday, February 8, 2018NON-FINAL ACTION WRITTEN
Friday, February 2, 2018ASSIGNED TO EXAMINER
Friday, November 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 11, 2017NEW APPLICATION ENTERED

Related Keywords

trazimera cancer treatment preparations pharmaceutical